Related Experiment Video
Updated: Jun 9, 2026

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Potentiation of cocaine hepatotoxicity in human hepatocytes by ethanol
X Ponsoda1, R Jover, J V Castell
1Unidad de Hepatología Experimental, Centro de Investigación, Hospital Universitario "La Fe", SVS. Avda. Campanar 21, E-46009 Valencia, Spain.
Abstract:
The cytotoxic effect of cocaine on human hepatocytes was evaluated after 24 hr of exposure to cocaine by measuring the leakage of intracellular lactate dehydrogenase and the reduction of MTT. According to these endpoint parameters, the half-maximal cytotoxic concentration (IC(50)) of cocaine was 6.8 and 7.8 mm, respectively. Lower concentrations of cocaine, however, impaired basic metabolic functions of human hepatocytes. Exposure of cells to 2 mm-cocaine resulted in a 50% decrease in hepatic glycogen, a 40% decrease in cellular glutathione content and a 40% decrease in urea synthesis with respect to control values. Ethanol greatly potentiated cocaine-induced hepatotoxicity. After a 48-hr pretreatment of human hepatocytes with 50 mm-ethanol, concentrations of cocaine (0.25 mm) that had no effects on hepatocyte metabolism in the absence of ethanol, caused a 20% inhibition of the urea synthesis rate, a 40% depletion of glycogen stores and a 30% reduction in glutathione content. The results of our work show that ethanol significantly increases the toxic effects of cocaine on human hepatocytes.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug toxicity: Drug–Drug Interaction
Drug Toxicity: Dose-Dependent Reactions
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

